MAS-1, A Novel Water-In-Oil Adjuvant/Delivery System, With Reduced Seasonal Influenza Vaccine Hemagglutinin Dose May Enhance Potency, Durability and Cross-Reactivity of Antibody Responses in the Elderly

Go back to Resources

MAS-1, A Novel Water-In-Oil Adjuvant/Delivery System, With Reduced Seasonal Influenza Vaccine Hemagglutinin Dose May Enhance Potency, Durability and Cross-Reactivity of Antibody Responses in the Elderly

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

EVITA Dengue: a Cluster-Randomized Controlled Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral Infection in Brazil

Go back to Resources

EVITA Dengue: a Cluster-Randomized Controlled Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral Infection in Brazil

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Qualitative Results from NIDA Grant

Go back to Resources

Qualitative Results from NIDA Grant

Authors:

Secondary:

Volume:

Issue:

Abstract:

Go back to Resources

Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy

Go back to Resources

Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Maternal Body Composition and Gestational Weight Gain in Relation to Asthma Control During Pregnancy

Go back to Resources

Maternal Body Composition and Gestational Weight Gain in Relation to Asthma Control During Pregnancy

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E

Go back to Resources

First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study

Go back to Resources

The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.

Go back to Resources

Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects

Go back to Resources

A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

Go back to Resources

Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Subscribe to